Whether it’s solving a complex patient’s puzzle to determine a tricky diagnosis, or a simple triple check that averted disaster, these moments serve a special satisfaction.
Scientists from Arthritis Research Canada found a significant drop in all-cause mortality and major adverse cardiovascular events in people from the group who took glucagon-like peptide-1 receptor agonists.
In April 2023, community pharmacies reported 721 near-misses to ISMP Canada. It shared the most common problems—and suggested solutions—in a new bulletin.